Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro

Journal of Cell Science

Volumn 123, Issue 20, 2010, Pages 3507-3514

  Gao, Ming Qing ^a   Kim, Baek Gil ^a   Kang, Suki ^a   Choi, Yoon Pyo ^a   Park, Hangran ^a   Kang, Kyu Sub ^a   Cho, Nam Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Breast carcinoma; Epithelial mesenchymal transition; Interface fibroblasts; Stromal fibroblasts; Tumor microenvironment; Tumor zones

Indexed keywords

MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; VIMENTIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER TISSUE; CELL GROWTH; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR GROWTH;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MATRIX METALLOPROTEINASE 14; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 77957870040     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.072900     Document Type: Article

References (29)

1. Acharya, P. S., Zukas, A., Chandan, V., Katzenstein, A. L. and Pure, E. (2006). Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum. Pathol. 37, 352-360.
2. Bhowmick, N. A., Neilson, E. G. and Moses, H. L. (2004). Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337.
3. De Wever, O., Pauwels, P., De Craene, B., Sabbah, M., Emami, S., Redeuilh, G., Gespach, C., Bracke, M. and Berx, G. (2008). Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem. Cell Biol. 130, 481-494.
4. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D. and Jorgensen, C. (2003). Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837-3844.
5. Doehn, U., Hauge, C., Frank, S. R., Jensen, C. J., Duda, K., Nielsen, J. V., Cohen, M. S., Johansen, J. V., Winther, B. R., Lund, L. R. et al. (2009). RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol. Cell 35, 511-522.
6. Gingras, D., Bousquet-Gagnon, N., Langlois, S., Lachambre, M. P., Annabi, B. and Beliveau, R. (2001). Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 507, 231-236.
7. Han, A. C., Soler, A. P., Knudsen, K. A. and Salazar, H. (1999). Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum. Pathol. 30, 1035-1039.
8. Holmgren, L., O'Reilly, M. S. and Folkman, J. (1995). Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1, 149-153.
9. Horn, G., Gaziel, A., Wreschner, D. H., Smorodinsky, N. I. and Ehrlich, M. (2009). ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. Exp. Cell Res. 315, 1490-1504.
10. Itoh, Y. (2006). MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life 58, 589-596.
11. Kang, S., Shim, H. S., Lee, J. S., Kim, D. S., Kim, H. Y., Hong, S. H., Kim, P. S., Yoon, J. H. and Cho, N. H. (2010). Molecular proteomics imaging of tumor interfaces by mass spectrometry. J. Proteome Res. 9, 1157-1164.
12. Lakka, S. S., Jasti, S. L., Gondi, C., Boyd, D., Chandrasekar, N., Dinh, D. H., Olivero, W. C., Gujrati, M. and Rao, J. S. (2002). Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21, 5601-5608.
13. Lebret, S. C., Newgreen, D. F., Thompson, E. W. and Ackland, M. L. (2007). Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res. 9, R19.
14. Li, Y., Yang, J., Dai, C., Wu, C. and Liu, Y. (2003). Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J. Clin. Invest. 112, 503-516.
15. Mueller, M. M. and Fusenig, N. E. (2004). Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839-849.
16. Oda, T., Takahashi, A., Miyao, N., Yanase, M., Masumori, N., Itoh, N., Sato, M. A., Kon, S. and Tsukamoto, T. (2003). Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma. Int. J. Urol. 10, 13-18.
17. Olumi, A. F., Grossfeld, G. D., Hayward, S. W., Carroll, P. R., Tlsty, T. D. and Cunha, G. R. (1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002-5011.
18. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L. and Weinberg, R. A. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
19. Orlichenko, L. S. and Radisky, D. C. (2008). Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin. Exp. Metastasis 25, 593-600.
20. Park, J. E., Lenter, M. C., Zimmermann, R. N., Garin-Chesa, P., Old, L. J. and Rettig, W. J. (1999). Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 274, 36505-36512.
21. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Nieto, M. A. et al. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-127.
22. Sgroi, D. C. (2010). Preinvasive breast cancer. Annu. Rev. Pathol. 5, 193-221.
23. Shekhar, M. P., Werdell, J., Santner, S. J., Pauley, R. J. and Tait, L. (2001). Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res. 61, 1320-1326.
24. Singer, C. F., Kronsteiner, N., Marton, E., Kubista, M., Cullen, K. J., Hirtenlehner, K., Seifert, M. and Kubista, E. (2002). MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res. Treat 72, 69-77.
25. Strongin, A. Y. (2006). Mislocalization and unconventional functions of cellular MMPs in cancer. Cancer Metastasis Rev. 25, 87-98.
26. Takino, T., Miyamori, H., Watanabe, Y., Yoshioka, K., Seiki, M. and Sato, H. (2004). Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res. 64, 1044-1049.
27. Thiery, J. P. (2003). Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746.
28. Tomita, K., van Bokhoven, A., van Leenders, G. J., Ruijter, E. T., Jansen, C. F., Bussemakers, M. J. and Schalken, J. A. (2000). Cadherin switching in human prostate cancer progression. Cancer Res. 60, 3650-3654.
29. Zeisberg, M. and Kalluri, R. (2004). The role of epithelial-to- mesenchymal transition in renal fibrosis. J. Mol. Med. 82, 175-181.